Pharmafile Logo

Dedicated

- PMLiVE

GSK still waiting for new respiratory drugs to lift off

But still posts strong growth thanks to HIV drugs and vaccines

Mirna Therapeutics appoints new executive vice president

Miguel Barbosa willalso serve as chief scientific officer

- PMLiVE

Getting patients to engage with clinical trials

The EUPATI European initiative and increasing public knowledge of research

Bristol-Myers Squibb (BMS) building

BMS’ Yervoy receives additional FDA approval

Gives the nod for Yervoy as adjuvant treatment option for melanoma

- PMLiVE

Synergy Vision in Asia-Pacific push

New Sydney office willbe headed up by Corinne Whitehead

- PMLiVE

PBMs drop Philidor, and Valeant follows suit

Comes after allegations of impropriety

- PMLiVE

Allergan/Pfizer takeover talks confirmed

Talks still in early stage with no certainty of deal

- PMLiVE

FDA approves Merrimack’s pancreatic cancer drug

Onivyde improves overall survival rates

Asana appoints new chief medical officer

Louis Denis joins from Boehringer Ingelheim

- PMLiVE

Baxter appoints Jose Almeida chairman and CEO

Will take over from Robert Parkinson Jr in Janary

- PMLiVE

Novartis’ Cosentyx off to a flyer in psoriasis

Year-to-date sales reach $140m for recently approved drug

- PMLiVE

FDA approves Janssen’s Yondelis

Provides additional treatment option for softtissue sarcoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links